PREGNANCY IN PATIENTS WITH CHRONIC KIDNEY DISEASE

(1)   Dunlop W. Serial changes in renal hemodynamics during normal human pregnancy. Br J Obstet Gynaecol. 1981;88(1):1–9.

(2)   Faundes A, Bricola-Filho M, Pinto e Silva JL. Dilatation of the urinary tract during pregnancy: proposal of a curve of maximal caliceal diameter by gestational age. Am J Obstet Gynecol. 1998;178(5):1082–1086.

(3)   Rasmussen PE, Nielson FR. Hydronephrosis in pregnancy: a literature survey. Eur J Obstet Gynecol Reprod Biol. 1988;27(3):249–259.

(4)   Smith MC, Moran P, Ward MK, Davison JM. Assessment of glomerular filtration rate during pregnancy using the MDRD formula. Br J Obstet Gynaecol 2008;115:109-112.

(5)   Koetje PM, Spaan JJ, Kooman JP, Spaanderman ME, Peeters LL. Pregnancy reduces the accuracy of the estimated glomerular filtration rate based on Cockroft-Gault and MDRD formulas. Reprod Sci. 2011;18:456–462.

(6)   Eknoyan G, Hostetter T, Bakris GL, et al. Proteinuria and other markers of chronic kidney disease: A position statement of the National Kidney Foundation (NKF) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Am J Kidney Dis 2003;2:617-622

(7)   American College of Obstetricians and Gynecologists. Diagnosis and management of preeclampsia and 

eclampsia. Int J Gynaecol Obstet 2002;77:67-75.    

(8)   Price CP, Newall RG, Boyd JC. Use of protein: Creatinine ratio measurements on random urine 

samples for prediction of significant proteinuria. A systematic review. Clin Chem 2005;51:1577-1586.

(9)   Munkhaugen J, Lydersen S, Romundstad PR, Wideroe TE, Vikse BE, Hallan S. Kidney function and future risk for adverse pregnancy outcomes: a population-based study from HUNT II, Norway. Nephrol Dial Transplant. 2009;24:3744–3750.

(10)   Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038–2047.

(11)   Smyth A, Oliveira GH, Lahr BD, Bailey KR, Norby SM, Garovic VD. A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. CJASN. 2010;5:2060–2068.

(12)   Piccoli GB, Pia A, Vigotti F, et al. Autosomal dominant polycystic kidney disease: what do we need to know for counselling? EMJ Neph. 2014;2(1):51–60.

(13)    Limardo M, Imbasciati E, Ravani P, et al. Pregnancy and progression of IgA nephropathy: results of an Italian multicenter study. Am J Kidney Dis. 2010;56:506–512.

(14)   Piccoli GB, Clari R, Ghiotto S, et al. Type 1 diabetes, diabetic nephropathy, and pregnancy: a systematic review and meta-study. Rev Diabet Stud. 2013;10:6–26.

(15)  Bell R, Glinianaia SV, Tennant PW, Bilous RW, Rankin J. Peri-conception hyperglycaemia and nephropathy are associated with risk of congenital anomaly in women with pre-existing diabetes: a population-based cohort study. Diabetologia. 2012;55:936–947.

(16) Bramham K, Lightstone L. Pre-pregnancy counseling for women with chronic kidney disease. J Nephrol. 2012;25:450–459.

(17)  Wiles KS, Bramham K, Vais A, et al. Pre-pregnancy counselling for women with chronic kidney disease: a retrospective analysis of nine years’ experience. BMC Nephrol. 2015;16:28.

(18)  Webster P, Wardle A, Bramham K, Webster L, Nelson-Piercy C, Lightstone L. Tacrolimus is an effective treatment for lupus nephritis in pregnancy. Lupus. 2014;23:1192–1196.

(19)   Stanhope TJ, White WM, Moder KG, Smyth A, Garovic VD. Obstetric nephrology: lupus and lupus nephritis in pregnancy. CJASN. 2012;7:2089–2099.

(20)   Bramham K, Rajasingham D. Pregnancy in diabetes and kidney disease. J Ren Care. 2012;38(Suppl 1):78–89.

(21)  Bramham K, Lightston L. Karoshi MNS, B-Lynch C, Keith L. A Textbook of Preconceptual Medicine and Management. Carlisle: Sapiens Publishing Ltd; 2012. Preconceptual counseling for women with chronic kidney disease.

(22)   COG Practice Bulletin No 77: screening for fetal chromosomal abnormalities. Obstet Gynecol. 2007;109(1):217–227.

(23)  Bramham K, Parnell B, Nelson-Piercy C, Seed PT, Poston L, Chappell LC. Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis. BMJ. 2014;348:g2301.

(24)  on Dadelszen P, Ornstein MP, Bull SB, Logan AG, Koren G, Magee LA. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet. 2000;355:87–92.

(25)  SOMANZ [Internet] Guideline for the Management of Hypertensive Disorders of Pregnancy. 2014. [Accessed October 18, 2015].

(26) Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. NEJM. 2006;354:2443–2451.

(27)  Li DK, Yang C, Andrade S, Tavares V, Ferber JR. Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study. BMJ. 2011;343:d5931.

(28)  Nevis IF, Reitsma A, Dominic A, et al. Pregnancy outcomes in women with chronic kidney disease: a systematic review. CJASN. 2011;6:2587–2598.

(29)                       Piccoli GB, Cabiddu G, Attini R, et al. Pregnancy in CKD: questions and answers in a changing panorama. Best Pract Res Clin Obstet Gynaecol. 2015;29

(30)   Saliem S, Patenaude V, Abenhaim H. Pregnancy outcomes among renal transplant recipients and patients with end-stage renal disease on dialysis. J Perinat Med. 2016;44(3):321–327.

(31)  Cabiddu G, Castellino S, Gernone G, et al. Best practices on pregnancy on dialysis: the Italian Study Group on Kidney and Pregnancy. J Nephrol. 2015;28:279–288.

(32)   Alkhunaizi A, Melamed N, Hladunewich MA. Pregnancy in advanced chronic kidney disease and end-stage renal disease. Curr Opin Nephrol Hypertens. 2015;24:252–259.

(33)   Jesudason S, Grace BS, McDonald SP. Pregnancy outcomes according to dialysis commencing before or after conception in women with ESRD. CJASN. 2014;9:143–149.

(34)   Piccoli GB, Cabiddu G, Daidone G, et al. The children of dialysis: live-born babies from on-dialysis mothers in Italy – an epidemiological perspective comparing dialysis, kidney transplantation and the overall population. Nephrol Dial Transplant. 2014;29:1578–1586.

(35)  Wyld ML, Clayton PA, Kennedy S, Alexander SI, Chadban SJ. Pregnancy outcomes for kidney transplant recipients with transplantation as a child. JAMA. 2015;169:1–6.

(36)   Bramham K, Nelson-Piercy C, Gao H, et al. Pregnancy in renal transplant recipients: a UK national cohort study. CJASN. 2013;8:290–298.

(37)  KDIGO KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant. 2009;9(Suppl 3):S1–S155.

(38)   Josephson MA, McKay DB. Women and transplantation: fertility, sexuality, pregnancy, contraception. Adv Chronic Kidney Dis. 2013;20:433–440.

(39)   Kim H, Jeong J, Yang W, et al. The optimal therapy of calcineurin inhibitors for pregnancy in kidney transplantation. Clin Transplant. 2015;29:142–148.

(40)   Framarino-dei-Malatesta M, Derme M, Napoli A, et al. Placental, lipid, and glucidic effects of mammalian target of rapamycin inhibitors: impact on fetal growth and metabolic disorders during pregnancy after solid organ transplantation. Transplant Proc. 2014;46:2254–2258.